These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 37091369)

  • 1. Perspectives on Usage of Functional Nanomaterials in Antimicrobial Therapy for Antibiotic-Resistant Bacterial Infections.
    Karnwal A; Kumar G; Pant G; Hossain K; Ahmad A; Alshammari MB
    ACS Omega; 2023 Apr; 8(15):13492-13508. PubMed ID: 37091369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomaterials: The New Antimicrobial Magic Bullet.
    Ndayishimiye J; Kumeria T; Popat A; Falconer JR; Blaskovich MAT
    ACS Infect Dis; 2022 Apr; 8(4):693-712. PubMed ID: 35343231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms.
    Lee NY; Ko WC; Hsueh PR
    Front Pharmacol; 2019; 10():1153. PubMed ID: 31636564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal nanobullets for multidrug resistant bacteria and biofilms.
    Chen CW; Hsu CY; Lai SM; Syu WJ; Wang TY; Lai PS
    Adv Drug Deliv Rev; 2014 Nov; 78():88-104. PubMed ID: 25138828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcal Bacterial Persister Cells, Biofilms, and Intracellular Infection Are Disrupted by JD1, a Membrane-Damaging Small Molecule.
    Dombach JL; Quintana JLJ; Detweiler CS
    mBio; 2021 Oct; 12(5):e0180121. PubMed ID: 34634935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal, quorum quenching and anti-biofilm nanofactories: a new niche for nanotechnologists.
    Singh BN; Prateeksha ; Upreti DK; Singh BR; Defoirdt T; Gupta VK; De Souza AO; Singh HB; Barreira JC; Ferreira IC; Vahabi K
    Crit Rev Biotechnol; 2017 Jun; 37(4):525-540. PubMed ID: 27684212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of Nanoparticles Integrated with Antibacterial Properties in Preventing Biofilm and Antibiotic Resistance.
    Thambirajoo M; Maarof M; Lokanathan Y; Katas H; Ghazalli NF; Tabata Y; Fauzi MB
    Antibiotics (Basel); 2021 Nov; 10(11):. PubMed ID: 34827276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives.
    Hetta HF; Ramadan YN; Al-Harbi AI; A Ahmed E; Battah B; Abd Ellah NH; Zanetti S; Donadu MG
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Nanoparticles in the Inhibition of Multidrug-Resistant Bacteria and Biofilms.
    AlMatar M; Makky EA; Var I; Koksal F
    Curr Drug Deliv; 2018; 15(4):470-484. PubMed ID: 29219055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
    Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
    J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential of Antibiotics and Nanomaterial Combinations as Therapeutic Strategies in the Management of Multidrug-Resistant Infections: A Review.
    Adeniji OO; Nontongana N; Okoh JC; Okoh AI
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How nanomaterials act against bacterial structures? a narrative review focusing on nanoparticle molecular mechanisms.
    Bahrami M; Serati Shirazi P; Moradi F; Hadi N; Sabbaghi N; Eslaminezhad S
    Microb Pathog; 2024 Nov; 196():107002. PubMed ID: 39393474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in the Development of Lipid-, Metal-, Carbon-, and Polymer-Based Nanomaterials for Antibacterial Applications.
    Ren R; Lim C; Li S; Wang Y; Song J; Lin TW; Muir BW; Hsu HY; Shen HH
    Nanomaterials (Basel); 2022 Nov; 12(21):. PubMed ID: 36364631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoantibiotics: A Novel Rational Approach to Antibiotic Resistant Infections.
    Engin AB; Engin A
    Curr Drug Metab; 2019; 20(9):720-741. PubMed ID: 31385767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancements in Nanoparticle-Based Strategies for Enhanced Antibacterial Interventions.
    Moradialvand M; Asri N; Jahdkaran M; Beladi M; Houri H
    Cell Biochem Biophys; 2024 Dec; 82(4):3071-3090. PubMed ID: 39023679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress and prospects of nanomaterials against resistant bacteria.
    He J; Hong M; Xie W; Chen Z; Chen D; Xie S
    J Control Release; 2022 Nov; 351():301-323. PubMed ID: 36165865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles as antibiotic-delivery vehicles (ADVs) overcome resistance by MRSA and other MDR bacterial pathogens: The grenade hypothesis.
    Alabresm A; Chen YP; Wichter-Chandler S; Lead J; Benicewicz BC; Decho AW
    J Glob Antimicrob Resist; 2020 Sep; 22():811-817. PubMed ID: 32653724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review on Nano-Antimicrobials: Metal Nanoparticles, Methods and Mechanisms.
    Hoseinzadeh E; Makhdoumi P; Taha P; Hossini H; Stelling J; Kamal MA; Ashraf GM
    Curr Drug Metab; 2017; 18(2):120-128. PubMed ID: 27908256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections.
    Elfadil D; Elkhatib WF; El-Sayyad GS
    Microb Pathog; 2022 Sep; 170():105721. PubMed ID: 35970290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.